[English] 日本語

- EMDB-51524: Maps from particle subsets of methylamine treated human complemen... -
+
Open data
-
Basic information
Entry | ![]() | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Title | Maps from particle subsets of methylamine treated human complement C3 showing three distinct ANA positions | ||||||||||||
![]() | C3MA map showing ANA position #2 | ||||||||||||
![]() |
| ||||||||||||
![]() | Complement / nanobody / IMMUNE SYSTEM | ||||||||||||
Biological species | ![]() ![]() ![]() | ||||||||||||
Method | single particle reconstruction / cryo EM / Resolution: 3.9 Å | ||||||||||||
![]() | Joergensen MH / Andersen GR | ||||||||||||
Funding support | ![]()
| ||||||||||||
![]() | ![]() Title: Cryo-EM analysis of complement C3 reveals a reversible major opening of the macroglobulin ring. Authors: Trine Amalie Fogh Gadeberg / Martin Høgholm Jørgensen / Heidi Gytz Olesen / Josefine Lorentzen / Seandean Lykke Harwood / Ana Viana Almeida / Marlene Uglebjerg Fruergaard / Rasmus Kjeldsen ...Authors: Trine Amalie Fogh Gadeberg / Martin Høgholm Jørgensen / Heidi Gytz Olesen / Josefine Lorentzen / Seandean Lykke Harwood / Ana Viana Almeida / Marlene Uglebjerg Fruergaard / Rasmus Kjeldsen Jensen / Philipp Kanis / Henrik Pedersen / Emil Tranchant / Steen Vang Petersen / Ida Buch Thøgersen / Birthe Brandt Kragelund / Joseph Anthony Lyons / Jan Johannes Enghild / Gregers Rom Andersen / ![]() Abstract: The C3 protein is the central molecule within the complement system and undergoes proteolytic activation to C3b in the presence of pathogens. Pattern-independent activation of C3 also occurs via ...The C3 protein is the central molecule within the complement system and undergoes proteolytic activation to C3b in the presence of pathogens. Pattern-independent activation of C3 also occurs via hydrolysis, resulting in C3(HO), but the structural details of C3 hydrolysis remain elusive. Here we show that the conformation of the C3(HO) analog, C3MA, is indistinguishable from C3b. In contrast, the reaction intermediate C3* adopts a conformation dramatically different from both C3 and C3MA. In C3*, unlocking of the macroglobulin (MG) 3 domain creates a large opening in the MG ring through which the anaphylatoxin (ANA) domain translocates through a transient opening. C3MA formation is inhibited by an MG3-specific nanobody and prevented by linking the ANA domain to the C3 β-chain. Our study reveals an unexpected dynamic behavior of C3 and forms the basis for elucidation of the in vivo contribution of C3 hydrolysis and for controlling complement upon intravascular hemolysis and surface-contact-induced activation. | ||||||||||||
History |
|
-
Structure visualization
Supplemental images |
---|
-
Downloads & links
-EMDB archive
Map data | ![]() | 339.8 MB | ![]() | |
---|---|---|---|---|
Header (meta data) | ![]() ![]() | 28.3 KB 28.3 KB | Display Display | ![]() |
Images | ![]() | 67.3 KB | ||
Filedesc metadata | ![]() | 4.6 KB | ||
Others | ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() | 338.4 MB 338.6 MB 338.7 MB 339.2 MB 338.4 MB 339.2 MB 340 MB 339.1 MB | ||
Archive directory | ![]() ![]() | HTTPS FTP |
-Related structure data
-
Links
EMDB pages | ![]() ![]() |
---|
-
Map
File | ![]() | ||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #2 | ||||||||||||||||||||||||||||||||||||
Projections & slices | Image control
Images are generated by Spider. | ||||||||||||||||||||||||||||||||||||
Voxel size | X=Y=Z: 0.647 Å | ||||||||||||||||||||||||||||||||||||
Density |
| ||||||||||||||||||||||||||||||||||||
Symmetry | Space group: 1 | ||||||||||||||||||||||||||||||||||||
Details | EMDB XML:
|
-Supplemental data
-Additional map: C3MA map showing ANA position #1
File | emd_51524_additional_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #1 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: C3MA map showing ANA position #1 half B
File | emd_51524_additional_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #1 half B | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: C3MA map showing ANA position #1 half A
File | emd_51524_additional_3.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #1 half A | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: C3MA map showing ANA position #3 half A
File | emd_51524_additional_4.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #3 half A | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: C3MA map showing ANA position #3
File | emd_51524_additional_5.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #3 | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Additional map: C3MA map showing ANA position #3 half B
File | emd_51524_additional_6.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #3 half B | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: C3MA map showing ANA position #2 half B
File | emd_51524_half_map_1.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #2 half B | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-Half map: C3MA map showing ANA position #2 half A
File | emd_51524_half_map_2.map | ||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Annotation | C3MA map showing ANA position #2 half A | ||||||||||||
Projections & Slices |
| ||||||||||||
Density Histograms |
-
Sample components
-Entire : methylamine treated complement C3 in complex with a nanobody enab...
Entire | Name: methylamine treated complement C3 in complex with a nanobody enabling dimer formation |
---|---|
Components |
|
-Supramolecule #1: methylamine treated complement C3 in complex with a nanobody enab...
Supramolecule | Name: methylamine treated complement C3 in complex with a nanobody enabling dimer formation type: complex / ID: 1 / Parent: 0 / Macromolecule list: #1-#2 |
---|---|
Source (natural) | Organism: ![]() |
Molecular weight | Theoretical: 185 KDa |
-Supramolecule #2: nanobody hC3Nb1 with mutation
Supramolecule | Name: nanobody hC3Nb1 with mutation / type: complex / ID: 2 / Parent: 1 / Macromolecule list: #2 |
---|---|
Source (natural) | Organism: ![]() ![]() |
-Supramolecule #3: complement C3
Supramolecule | Name: complement C3 / type: complex / ID: 3 / Parent: 1 / Macromolecule list: #1 |
---|---|
Source (natural) | Organism: ![]() |
-Experimental details
-Structure determination
Method | cryo EM |
---|---|
![]() | single particle reconstruction |
Aggregation state | particle |
-
Sample preparation
Concentration | 1.0 mg/mL |
---|---|
Buffer | pH: 7 |
Vitrification | Cryogen name: ETHANE |
-
Electron microscopy
Microscope | FEI TITAN KRIOS |
---|---|
Specialist optics | Energy filter - Name: GIF Bioquantum / Energy filter - Slit width: 20 eV |
Image recording | Film or detector model: GATAN K3 BIOQUANTUM (6k x 4k) / Average electron dose: 59.5 e/Å2 |
Electron beam | Acceleration voltage: 300 kV / Electron source: ![]() |
Electron optics | Illumination mode: FLOOD BEAM / Imaging mode: BRIGHT FIELD / Cs: 2.7 mm / Nominal defocus max: 2.438 µm / Nominal defocus min: 0.17 µm / Nominal magnification: 130000 |
Sample stage | Specimen holder model: FEI TITAN KRIOS AUTOGRID HOLDER / Cooling holder cryogen: NITROGEN |
Experimental equipment | ![]() Model: Titan Krios / Image courtesy: FEI Company |